Russell Investments Group’s Atea Pharmaceuticals AVIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $120K | Sell |
33,258
-21,644
| -39% | -$77.9K | ﹤0.01% | 2776 |
|
|
2025
Q1 | $164K | Buy |
54,902
+54,398
| +10,793% | +$163K | ﹤0.01% | 2645 |
|
|
2024
Q4 | $1.69K | Sell |
504
-598
| -54% | -$2K | ﹤0.01% | 3469 |
|
|
2024
Q3 | $3.69K | Buy |
1,102
+598
| +119% | +$2K | ﹤0.01% | 3279 |
|
|
2024
Q2 | $1.67K | Sell |
504
-170
| -25% | -$563 | ﹤0.01% | 3374 |
|
|
2024
Q1 | $2.72K | Sell |
674
-4,236
| -86% | -$17.1K | ﹤0.01% | 3031 |
|
|
2023
Q4 | $15K | Buy |
4,910
+241
| +5% | +$735 | ﹤0.01% | 2782 |
|
|
2023
Q3 | $14K | Buy |
4,669
+161
| +4% | +$483 | ﹤0.01% | 2939 |
|
|
2023
Q2 | $16.9K | Hold |
4,508
| – | – | ﹤0.01% | 2870 |
|
|
2023
Q1 | $15.1K | Sell |
4,508
-12,500
| -73% | -$41.9K | ﹤0.01% | 2844 |
|
|
2022
Q4 | $81.8K | Buy |
17,008
+12,500
| +277% | +$60.1K | ﹤0.01% | 2695 |
|
|
2022
Q3 | $25K | Buy |
4,508
+905
| +25% | +$5.02K | ﹤0.01% | 2794 |
|
|
2022
Q2 | $26K | Sell |
3,603
-5,939
| -62% | -$42.9K | ﹤0.01% | 2775 |
|
|
2022
Q1 | $67K | Sell |
9,542
-155,420
| -94% | -$1.09M | ﹤0.01% | 2608 |
|
|
2021
Q4 | $1.48M | Buy |
164,962
+22,448
| +16% | +$201K | ﹤0.01% | 1953 |
|
|
2021
Q3 | $4.93M | Buy |
142,514
+140,818
| +8,303% | +$4.88M | 0.01% | 1262 |
|
|
2021
Q2 | $41K | Buy |
+1,696
| New | +$41K | ﹤0.01% | 3147 |
|